Inhibitor (Human) Injection
Products Affected - Description
Berinert intravenous injection, CSL Behring
500 unit, preservative-free vial (NDC 63833-0825-02)
Cinryze intravenous injection, Shire
500 unit, preservative-free vial (NDC 42227-0081-05)
Reason for the Shortage
CSL Behring has Berinert on shortage due to increased demand.
Shire has Cinryze on back order due to manufacturing delay.
The subcutaneous dosage form of C1-esterase inhibitor (human) is unaffected by this shortage.
Available Products
There is insufficient supply for usual ordering
Estimated Resupply Dates
CSL Behring is shipping limited supplies of Berinert to specialty distributers.
Shire has Cinryze injection on back order and the company cannot estimate a release date.
Updated
October 4, 2017, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT